Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
Clicks: 289
ID: 6607
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
71.7
/100
289 views
237 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #37 of 194 articles by views in journal of hepatocellular carcinoma
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 194 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (15 words).
Try re-searching for a better abstract.
| Reference Key |
lichun2019targetingjournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Li-Chun Lu;Chun-Jung Chang;Chih-Hung Hsu and |
| Journal | journal of hepatocellular carcinoma |
| Year | 2019 |
| DOI |
10.2147/JHC.S159693
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.